Gene Expression Profiling and RNA Sequencing
This dataset provides comprehensive RNA sequencing profiles, including gene expression quantification, differential expression analysis, pathway associations, fusion transcript detection, and molecular subtyping for each biological sample. It is designed for advanced research and clinical diagnostics, enabling biomarker discovery, disease classification, and pathway-driven insights in genomics.
Sample rows
preview · 8 of 110 rows · all 19 columns| sample_idstring | differential_expression_statusstring | adjusted_p_valuefloat | platformstring | sample_typestring | collection_datedate | gene_symbolstring | ensembl_idstring | expression_valuefloat | fold_changefloat | p_valuefloat | pathway_namestring | pathway_idstring | fusion_transcript_namestring | fusion_transcript_supportinteger | molecular_subtypestring | diagnosisstring | analysis_datedate | analyst_namestring |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SMP00001 | upregulated | 0.0031 | Illumina | tissue | 2023-08-11 | BRCA1 | ENSG00000012048 | 80.2 | 9.8 | 0.0012 | DNA Repair Pathway | KEGG:hsa03440 | blank | blank | Luminal A | Breast Cancer | 2023-08-13 | Dr. A. Kim |
| SMP00002 | not_significant | blank | Illumina | blood | 2021-02-17 | CD19 | ENSG00000177455 | 24.7 | blank | blank | B cell receptor signaling | KEGG:hsa04662 | blank | blank | Normal | Healthy Donor | 2021-02-19 | R. Gomez |
| SMP00003 | upregulated | 0.021 | BGISEQ | cell_line | 2018-11-22 | KRAS | ENSG00000133703 | 49.1 | 3.5 | 0.015 | MAPK signaling pathway | KEGG:hsa04010 | KRAS-ALK | 32 | KRAS-mutant | Colorectal Cancer Cell Line | 2018-11-24 | Cell Analysis Team |
| SMP00004 | downregulated | 0.046 | Illumina | tissue | 2022-04-06 | TP53 | ENSG00000141510 | 110.6 | 0.251 | 0.037 | Cell cycle | KEGG:hsa04110 | blank | blank | Triple Negative | Breast Cancer | 2022-04-08 | Dr. S. Lee |
| SMP00005 | upregulated | 0.018 | PacBio | other | 2024-01-18 | NTRK1 | ENSG00000198400 | 35.7 | 8.3 | 0.009 | Neurotrophin signaling | KEGG:hsa04722 | NTRK1-ETV6 | 77 | Gene Fusion | Thyroid Cancer | 2024-01-20 | FusionSeq Team |
| SMP00006 | downregulated | 0.0071 | Ion Proton | cell_line | 2023-05-27 | PTEN | ENSG00000171862 | 0.09 | 0.0002 | 0.0028 | PI3K-Akt signaling | KEGG:hsa04151 | blank | blank | PTEN-loss | Prostate Cancer Cell Line | 2023-05-28 | Dr. J. Wang |
| SMP00007 | upregulated | 0.016 | Illumina | tissue | 2019-03-14 | EGFR | ENSG00000146648 | 56.8 | 12.6 | 0.0082 | ErbB signaling pathway | KEGG:hsa04012 | blank | blank | HER2+ | Gastric Cancer | 2019-03-16 | J. Patel |
| SMP00008 | not_significant | blank | Illumina | blood | 2020-08-04 | HBB | ENSG00000244734 | 18.4 | blank | blank | Hemoglobin synthesis | REACT:R-HSA-123456 | blank | blank | Normal | Volunteer | 2020-08-06 | M. Hardy |
| SMP00009 | upregulated | 0.0094 | Illumina | cell_line | 2022-09-30 | ALK | ENSG00000171094 | 54.6 | 5.9 | 0.0038 | Oncogenic signaling | REACT:R-HSA-6805567 | ALK-EML4 | 120 | ALK Fusion | Lung Cancer Cell Line | 2022-10-02 | FusionSeq Team |
| SMP00010 | downregulated | 0.049 | Ion Torrent | other | 2017-06-15 | CDKN2A | ENSG00000147889 | 3.4 | 0.302 | 0.042 | Cell cycle control | KEGG:hsa04115 | blank | blank | Melanoma Subtype | Melanoma | 2017-06-17 | Melanoma Study Group |
| SMP00011 | upregulated | 0.00006 | Ion Proton | tissue | 2021-12-03 | MYC | ENSG00000136997 | 99999.99 | 400 | 0.00001 | Cellular proliferation | KEGG:hsa05206 | blank | blank | MYC-amplified | Lymphoma | 2021-12-06 | Dr. L. Smith |
| SMP00012 | not_significant | blank | Illumina | blood | 2019-07-21 | GATA1 | ENSG00000107485 | 12.6 | blank | blank | Erythropoiesis | KEGG:hsa04918 | blank | blank | Normal | Healthy Donor | 2019-07-22 | Dr. P. Yoon |
| SMP00013 | downregulated | 0.099 | Illumina | tissue | 2022-11-09 | ERBB2 | ENSG00000141736 | 7.4 | 0.51 | 0.095 | ErbB signaling pathway | KEGG:hsa04012 | blank | blank | HER2+ | Breast Cancer | 2022-11-12 | Dr. S. Lee |
| SMP00014 | upregulated | 0.000005 | BGISEQ | cell_line | 2020-04-20 | BRAF | ENSG00000157764 | 100000 | 175.2 | 0.000001 | MAPK signaling pathway | KEGG:hsa04010 | blank | blank | BRAF-mutant | Melanoma Cell Line | 2020-04-21 | Dr. N. Rao |
| SMP00015 | upregulated | 0.028 | PacBio | other | 2024-03-02 | EWSR1 | ENSG00000065320 | 2.9 | 2.4 | 0.019 | RNA processing pathway | REACT:R-HSA-72163 | EWSR1-FLI1 | 245 | Gene Fusion | Ewing Sarcoma | 2024-03-04 | FusionSeq Team |
| SMP00016 | not_significant | blank | Illumina | tissue | 2020-10-08 | CDK4 | ENSG00000135446 | 25.8 | blank | blank | Cell cycle | KEGG:hsa04110 | blank | blank | Luminal B | Breast Cancer | 2020-10-09 | J. Patel |
| SMP00017 | upregulated | 0.022 | Ion Proton | cell_line | 2021-05-11 | NTRK3 | ENSG00000140525 | 39.3 | 5.7 | 0.011 | Neurotrophin signaling | KEGG:hsa04722 | NTRK3-ETV6 | 11 | Gene Fusion | Pediatric Glioma Cell Line | 2021-05-12 | FusionSeq Team |
| SMP00018 | downregulated | 0.032 | Illumina | blood | 2022-06-23 | ALAS2 | ENSG00000158578 | 33.6 | 0.16 | 0.025 | Heme biosynthesis | KEGG:hsa00260 | blank | blank | Normal | Healthy Donor | 2022-06-26 | M. Hardy |
| SMP00019 | downregulated | 0.15 | Illumina | tissue | 2024-02-14 | BCL2 | ENSG00000171791 | 3.2 | 0.56 | 0.12 | Apoptosis | KEGG:hsa04210 | blank | blank | Follicular Subtype | Lymphoma | 2024-02-16 | Dr. L. Smith |
| SMP00020 | not_significant | blank | BGISEQ | cell_line | 2018-09-12 | CDK6 | ENSG00000105810 | 8.9 | blank | blank | Cell cycle | KEGG:hsa04110 | blank | blank | Normal Cell Line | Healthy Cell Line | 2018-09-15 | Cell Analysis Team |
What the 110 rows show
from the 110-row sampleUpregulated (differential expression status) stands out: mean adjusted_
- 0.02median adjusted_
p_ value - 4sample types
- 19.3median expression_
value - 4.5median fold_
change - 0.01median p_
value - 90.5median fusion_
transcript_ support
Median 0.02, from 0.00 to 0.22.
- string 12
- integer 1
- float 4
- date 2
Columns
19 columns in three groups| column | type | description | example |
|---|---|---|---|
| Text 12 columns | |||
sample_id | string | Unique identifier for each RNA sequencing sampleunique | SMP00001 |
sample_type | string | Type of biological sample (e.g., tissue, cell line, blood)tissue · cell_line · blood · other | tissue |
gene_symbol | string | Official gene symbol according to HGNC nomenclature | BRCA1 |
ensembl_id | string | Ensembl gene identifieroptional | ENSG00000012048 |
differential_expression_status | string | Indicates if the gene is differentially expressed in the sampleupregulated · downregulated · not_significant · optional | upregulated |
pathway_name | string | Name of biological pathway associated with the geneoptional | DNA Repair Pathway |
pathway_id | string | Unique identifier for the pathway (e.g., KEGG, Reactome)optional | KEGG:hsa03440 |
fusion_transcript_name | string | Name of detected fusion transcript (if any)optional | KRAS-ALK |
molecular_subtype | string | Assigned molecular subtype based on expression profilingoptional | Luminal A |
diagnosis | string | Clinical or research diagnosis associated with the sampleoptional | Breast Cancer |
analyst_name | string | Name of the person or team who performed the analysisoptional | Dr. A. Kim |
platform | string | Sequencing platform used (e.g., Illumina, Ion Torrent)6 platforms · optional | Illumina |
| Numbers 5 columns | |||
expression_value | float | Normalized gene expression value (e.g., TPM, FPKM)0 or more | 80.2 |
fold_change | float | Fold change of gene expression compared to control/referenceoptional | 9.8 |
p_value | float | Statistical significance of differential expression0 to 1 · optional | 0.0012 |
adjusted_p_value | float | Multiple testing corrected p-value (e.g., FDR)0 to 1 · optional | 0.0031 |
fusion_transcript_support | integer | Number of supporting reads for the fusion transcript0 or more · optional | 32 |
| Dates and times 2 columns | |||
collection_date | date | Date the sample was collectedoptional | 2023-08-11 |
analysis_date | date | Date when RNA sequencing analysis was performedoptional | 2023-08-13 |
Use it for
A healthcare dashboard
Adjusted_
p_ value by differential_ expression_ status and a breakdown of platform. Excel, Power BI or Tableau. Why do the 50 upregulated rows have a mean adjusted_
p_ value of 0.01? A root-cause class exercise
Hand out the rows and one question. The answer is in the data, not in the brief.
- Samples110SMP000010.0031upregula…SMP00002not_sign…SMP000030.021upregula…
A software demo
Believable samples with sample_
type, collection_ date and gene_ symbol to fill a screen in front of a buyer.
blueprint · gene-expression-profiling-and-rna-sequencing
Behind this dataset
Same schema. As many rows as you need.
These 110 rows came out of a blueprint — 19 columns with generation rules behind each one. Open it in Data Factory to retune a column, add your own, wire in foreign keys, and run it at the size you actually need.
- Sample ID unique per tissue or cell type
- RNA sequencing platform: Illumina, PacBio Iso-Seq
- Library type: total RNA, mRNA (poly-A), small RNA
- Read depth and length
- Gene-level expression: FPKM, TPM, or raw counts
- Differentially expressed genes (DEG): tumor vs normal
- Fold change and adjusted p-value (FDR)
- Pathway enrichment analysis: KEGG, GO terms
1 credit per row. Preview 20 rows free. Buy rows for the full run.
- Exports
- CSV, JSON, JSONL, Parquet, SQL, Excel, TSV, XML
- Licence
- yours to use, including commercially
- API slug
- gene-expression-profiling-and-rna-sequencing